TELA Bio Inc. held its Annual Meeting of Stockholders on May 28, 2025. During the meeting, stockholders approved the election of Jeffrey Blizard, Vince Burgess, and Federica O'Brien to the Board of Directors. Additionally, an amendment to the company's Amended and Restated 2019 Equity Incentive Plan was approved, which increases the authorized shares issuable under the plan by 3,500,000 shares and eliminates the "evergreen" provision.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.